Chris Kalberg

1.8k total citations
37 papers, 1.5k citations indexed

About

Chris Kalberg is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Chris Kalberg has authored 37 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Physiology, 28 papers in Pulmonary and Respiratory Medicine and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Chris Kalberg's work include Asthma and respiratory diseases (30 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (21 papers) and Respiratory and Cough-Related Research (15 papers). Chris Kalberg is often cited by papers focused on Asthma and respiratory diseases (30 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (21 papers) and Respiratory and Cough-Related Research (15 papers). Chris Kalberg collaborates with scholars based in United States, United Kingdom and Canada. Chris Kalberg's co-authors include Alison Church, Rashmi Mehta, Sally Kilbride, Colin Sumners, Bartolomé R. Celli, Kathy Rickard, Katharine Knobil, Amanda Emmett, James F. Donohue and Lisa Edwards and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, CHEST Journal and The American Journal of Medicine.

In The Last Decade

Chris Kalberg

36 papers receiving 1.4k citations

Peers

Chris Kalberg

PRM

PHYSI

CCM

Quan-ying He China

A Noseda Belgium

Leone Mattioli United States

Gabriel Dickstein Israel

C.J. Lamm Sweden

Corinne Caillaud France

Karin Vonbank Austria

C. Clark United Kingdom

Alessandra Scaparrotta Italy

Weibing Wu China

Quan-ying He China

Chris Kalberg

457 ×0.4

PRM

554 ×0.5

PHYSI

50 ×0.3

CCM

256 ×2.0

19 ×0.2

Citations per year, relative to Chris Kalberg Chris Kalberg (= 1×) peers Quan-ying He

Countries citing papers authored by Chris Kalberg

Since Specialization

Citations

This map shows the geographic impact of Chris Kalberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Kalberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Kalberg more than expected).

Fields of papers citing papers by Chris Kalberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chris Kalberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Kalberg. The network helps show where Chris Kalberg may publish in the future.

Co-authorship network of co-authors of Chris Kalberg

This figure shows the co-authorship network connecting the top 25 collaborators of Chris Kalberg. A scholar is included among the top collaborators of Chris Kalberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chris Kalberg. Chris Kalberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Riley, John, Chris Kalberg, Alison Donald, et al.. (2018). Effects of umeclidinium/vilanterol on exercise endurance in COPD: a randomised study. ERJ Open Research. 4(1). 73–2017. 10 indexed citations

Kerwin, Edward, Chris Kalberg, Dmitry Galkin, et al.. (2017). Umeclidinium/vilanterol as step-up therapy from tiotropium in patients with moderate COPD: a randomized, parallel-group, 12-week study. International Journal of COPD. Volume 12. 745–755. 29 indexed citations

Decramer, Marc, Antonio Anzueto, Nathalie Richard, et al.. (2014). Effect of the once-daily long-acting bronchodilator combination umeclidinium/vilanterol (UMEC/VI) and bronchodilator monotherapy on dyspnoea as measured by the transitional dyspnoea index (TDI) in COPD. European Respiratory Journal. 44(Suppl 58). P921–P921. 2 indexed citations

Celli, Bartolomé R., Glenn Crater, Sally Kilbride, et al.. (2014). Once-Daily Umeclidinium/Vilanterol 125/25 μg Therapy in COPD. CHEST Journal. 145(5). 981–991. 133 indexed citations

Singh, Dave, Chang‐Qing Zhu, Sanjay Sharma, Alison Church, & Chris Kalberg. (2014). Daily variation in lung function in COPD patients with combined albuterol and ipratropium: Results from a 4-week, randomized, crossover study. Pulmonary Pharmacology & Therapeutics. 31. 85–91. 6 indexed citations

Donohue, James F., M. Reza Maleki-Yazdi, Sally Kilbride, et al.. (2013). Efficacy and safety of once-daily umeclidinium/vilanterol 62.5/25 mcg in COPD. Respiratory Medicine. 107(10). 1538–1546. 219 indexed citations

Ferguson, Gary T., et al.. (2007). A RANDOMIZED, DOUBLE-BLIND TRIAL COMPARING THE EFFECT OF FLUTICASONE/SALMETEROL 250/50 TO SALMETEROL ON COPD EXACERBATIONS IN PATIENTS WITH COPD. CHEST Journal. 132(4). 530B–530B. 2 indexed citations

O’Donnell, Denis E., Frank C. Sciurba, Bartolomé R. Celli, et al.. (2006). Effect of Fluticasone Propionate/Salmeterol on Lung Hyperinflation and Exercise Endurance in COPD. CHEST Journal. 130(3). 647–656. 180 indexed citations

Knobil, Katharine, Kunal Merchant, Chris Kalberg, Amanda Emmett, & Michael J. Cicale. (2004). A Comparison of Patient Perceived Improvement in Symptoms After Initiating Therapy with Either Advair Diskus (fluticasone propionate/salmeterol) 250/50 or Ipratropium/Albuterol. CHEST Journal. 126(4). 806S–806S. 3 indexed citations

10.

Knobil, Katharine, Chris Kalberg, Kunal Merchant, Amanda Emmett, & Michael J. Cicale. (2004). Maintenance of Bronchodilator Response for Advair Diskus 250/50 (Fluticasone Propionate/Salmeterol) but not Ipratropium/Albuterol in Patients with COPD. CHEST Journal. 126(4). 807S–807S. 4 indexed citations

11.

Nathan, Robert A., et al.. (2002). Effect of fluticasone propionate/salmeterol combination product on activity induced bronchospasm in patients with persistent asthma. Journal of Allergy and Clinical Immunology. 109(1). S236–S236. 4 indexed citations

12.

Calhoun, William J., Harold S. Nelson, Robert A. Nathan, et al.. (2001). Comparison of Fluticasone Propionate–Salmeterol Combination Therapy and Montelukast in Patients Who Are Symptomatic on Short-acting β2-Agonists Alone. American Journal of Respiratory and Critical Care Medicine. 164(5). 759–763. 54 indexed citations

13.

Nelson, Harold S., R.A. Nathan, Chris Kalberg, Steve Yancey, & Kathy Rickard. (2001). Comparison of inhaled salmeterol and oral zafirlukast in asthmatic patients using concomitant inhaled corticosteroids.. PubMed. 3(4). 3–3. 31 indexed citations

14.

Bleecker, ER, Michael J. Welch, Chris Kalberg, et al.. (2000). Low-dose inhaled fluticasone propionate versus oral zafirlukast in the treatment of persistent asthma. Journal of Allergy and Clinical Immunology. 105(6). 1123–1129. 105 indexed citations

15.

Kalberg, Chris & Paul J. Ogren. (2000). An Inexpensive Convenient Press for KBr and CsI Pellets in Infrared Studies. Journal of Chemical Education. 77(3). 391–391. 1 indexed citations

16.

Knobil, Katharine, Chris Kalberg, Amanda Emmett, & Kathy Rickard. (1998). Adding salmeterol is more effective than increasing the dose of fluticasone for patients with asthma who are symptomatic on low dose fluticasone. 29. 19–20. 3 indexed citations

17.

Wenzel, Sally E., William R. Lumry, Michael Manning, et al.. (1998). Efficacy, Safety, and Effects on Quality of Life of Salmeterol Versus Albuterol in Patients with Mild to Moderate Persistent Asthma. Annals of Allergy Asthma & Immunology. 80(6). 463–470. 38 indexed citations

18.

Kemp, James P., David Cook, Gary A. Incaudo, et al.. (1998). Salmeterol improves quality of life in patients with asthma requiring inhaled corticosteroids. Journal of Allergy and Clinical Immunology. 101(2). 188–195. 56 indexed citations

19.

Sumners, Colin, Lara Myers, Chris Kalberg, & Mohan K. Raizada. (1990). Physiological and pharmacological comparisons of angiotensin II receptors in neuronal and astrocyte glial cultures. Progress in Neurobiology. 34(5). 355–385. 83 indexed citations

20.

Sumners, Colin, et al.. (1987). Norepinephrine metabolism in neuronal cultures is increased by angiotensin II. American Journal of Physiology-Cell Physiology. 252(6). C650–C656. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact